←
Springer Medicine2,125 posts
Springer Medicine avatar

Springer Medicine

@Springer_Med

Trustworthy, tailored, cutting-edge content for medical professionals who want to deliver the best possible care. #EdsChoice selections by the content team.

◷ Joined March 2023▧ 256 Photos and videos
Springer Medicine avatar
Springer Medicine@Springer_Med·Nov 16

How is emerging research poised to reshape #SjogrenDisease care? We speak with Prof. Raphaèle Seror about the advances driving momentum, the recent update in nomenclature, and what the future holds. Listen to our latest podcast now 👉 buff.ly/W7mGPUp #MedTwitter

0:39
Springer Medicine avatar
Springer Medicine@Springer_Med·Nov 15

PJP is increasingly recognized in patients with brain tumors undergoing immunosuppressive therapies. This review details risk determinants, diagnostic challenges, and evidence-informed approaches to prophylaxis and management. 👉 buff.ly/ksPaSNc #IDMed #OncTwitter

Springer Medicine avatar
Springer Medicine@Springer_Med·Nov 15

#MedNews - Recurrent visual field progression after an initial event in patients with #glaucoma is common and predicted by increased intraocular pressure as well as speed of visual field loss. 👉 buff.ly/5LXIepn #EyeMed

Springer Medicine avatar
Springer Medicine@Springer_Med·Nov 15

Navigate the rapidly evolving landscape of antibody–drug conjugates in biliary tract cancer with this review, focusing not only on the current evidence but also the challenges, such as the absence of phase 3 data. 👉 buff.ly/TyupHIe #OncTwitter

Springer Medicine avatar
Springer Medicine@Springer_Med·Nov 14

Multiple genotype-targeted therapies to slow or prevent #ParkinsonDisease have advanced through clinical trials, with key results expected soon. Explore promising developments targeting 𝘎𝘉𝘈1, 𝘓𝘙𝘙𝘒2, 𝘗𝘐𝘕𝘒1/𝘗𝘙𝘒𝘕 , and 𝘚𝘕𝘊𝘈. 👇 buff.ly/0bodBwV

Springer Medicine avatar
Springer Medicine@Springer_Med·Nov 14

Examine the rationale for early treatment in #CrohnsDisease, and review the evidence supporting early intervention to prevent transmural progression, an increased inflammatory burden, and associated refractory disease. 👉 buff.ly/dqAJnwr #GITwitter

Springer Medicine avatar
Springer Medicine@Springer_Med·Nov 14

#MedCase - A case highlighting the complexity of prolonged antimicrobial management of multifocal musculoskeletal infection and septic arthritis caused by N. brasiliensis in the setting of advanced NSCLC and CKD. 👉 buff.ly/6snPWD9 #IDMed

Springer Medicine avatar
Springer Medicine@Springer_Med·Nov 14

#MedCase - An uneventful cataract procedure took an unexpected turn when unfolding the intraocular lens triggered full-thickness dehiscence at a radial keratotomy scar, raising questions about trainee involvement in highly complex cases. 👉 buff.ly/qtVPn9q #EyeMed

Springer Medicine avatar
Springer Medicine@Springer_Med·Nov 13

A review of the latest evidence suggests many patients can start DOACs earlier than previously recommended, while decisions after intracerebral hemorrhage still require careful balancing of thromboembolic and bleeding risks. Find out more 👉 buff.ly/sJzOXQn #Stroke

Springer Medicine avatar
Springer Medicine@Springer_Med·Nov 13

#MedNews - Patients with rheumatoid arthritis who follow an early, strict treat-to-target strategy have high rates of clinical remission, minimal joint progression, and a survival rate comparable to that of the general population. 👉 buff.ly/Ks3RaNV #RheumTwitter

Springer Medicine avatar
Springer Medicine@Springer_Med·Nov 13

Targeted immunotherapies have substantially expanded therapeutic options for generalized myasthenia gravis. In the absence of validated predictive biomarkers and head-to-head trials, what should guide treatment selection? Find out here 👉 buff.ly/suLf7Cs #NeuroTwitter

Springer Medicine avatar
Springer Medicine@Springer_Med·Nov 13

#MedCase - Dermatomyositis should be considered whenever bilateral erythema of the proximal extremities, so-called sleeve and holster signs, accompanies muscle weakness even if the classic findings are absent. 👉 buff.ly/S2t1HfH #RheumTwitter

Springer Medicine avatar
Springer Medicine@Springer_Med·Nov 12

#MedNews - Modifiable vascular risk factors such as current smoking, hypertension, and diabetes, as well as a history of stroke, are associated with the development of late-onset #epilepsy. Full story 👉 buff.ly/qxQLSk3 #NeuroTwitter

Springer Medicine avatar
Springer Medicine@Springer_Med·Nov 12

Effective CIED infection prevention extends beyond peri-procedural antibiotic prophylaxis. This proposed three-tier framework maps patient-, procedure-, and device-related risk factors onto graded prevention strategies. 👉 buff.ly/HKuA1oF #CardioTwitter #IDMed

Springer Medicine avatar
Springer Medicine@Springer_Med·Nov 12

From #ESMO2026 - The phase 3 trial has shown a significant survival benefit with the antibody–drug conjugate sacituzumab tirumotecan among women with advanced endometrial cancer. 👉 buff.ly/m8H8v9C #MedNews